Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus



Status:Completed
Conditions:Diabetes
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:18 - 75
Updated:11/30/-0001
Start Date:January 2012
End Date:March 2013
Contact:Millie Gottwald, PharmD
Email:mgottwald@gilead.com
Phone:+1 (650) 522-5903

Use our guide to learn which trials are right for you!

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus


This is a randomized, double-blind, placebo-controlled, parallel-group, multicenter study to
determine the effect of ranolazine when added to glimepiride on glycemic control in subjects
with type 2 diabetes mellitus who are inadequately controlled despite current treatment with
stable sulfonylurea or metformin therapy in addition to diet and exercise.


This is a randomized, double-blind, placebo-controlled, parallel-group, multicenter study to
determine the effect of ranolazine when added to glimepiride on glycemic control in subjects
with type 2 diabetes mellitus (T2DM) who are inadequately controlled despite current
treatment with stable sulfonylurea or metformin therapy in addition to diet and exercise.
The study has been designed to determine the effect of ranolazine on glycemic control and to
characterize the relationship between HbA1c reduction and other glycemic parameters in
subjects with T2DM.

Inclusion Criteria:

- Written informed consent

- Males and females, 18 to 75 years old, inclusive

- Documented history of T2DM

- Receiving one of the following sulfonylurea (SU) or metformin therapies in addition
to diet and exercise for at least 90 days prior to Screening:

- glimepiride at a daily dose of ≥ 2 mg and ≤ 4 mg

- glimepiride at a daily dose of ≥ 1 mg and ≤ 2 mg for subjects with severe renal
impairment (eGFR < 30 mL/min/1.73m2 by the MDRD method)

- glipizide, glyburide, or glibenclamide (or equivalent) at a daily dose of ≥ 7.5
mg

- gliclazide at a daily dose of > 160 mg (or > 60 mg for the MR formulation)

- metformin at a daily dose of ≥ 1500 mg

- Body mass index (BMI) 27 kg/m2 to 45 kg/m2, inclusive, at Screening

- HbA1c 7% to 10%, inclusive, at Screening and at the end of Period 1 (Day 14 + 2 days)

- FSG ≥ 130 mg/dL (7.2 mmol/L) and ≤ 240 mg/dL (13.3 mmol/L) at Screening and at the
end of Period 1 (Day 14 +2 days)

- C-peptide > 1 ng/mL at Screening

Exclusion Criteria:

- History of type 1 diabetes mellitus

- History of acute or chronic ketoacidosis, ketosis-prone diabetes, or hyperosmolar
hyperglycemic coma

- History of a severe episode of hypoglycemia (eg, requiring assistance of another
person or active intervention of any kind) < 3 months prior to Screening

- Any clinically significant cardiovascular or cerebrovascular event (eg, MI, ACS,
recent revascularization [including coronary artery bypass graft procedures or
percutaneous coronary intervention], transient ischemic attack, or ischemic stroke) ≤
3 months prior to Screening

- Inadequately controlled or unstable hypertension as defined by a systolic blood
pressure (SBP) > 160 mmHg or diastolic blood pressure (DBP) > 100 mmHg at Screening
and at Period 2 Day 1

- Prolonged QTc interval > 500 msec by ECG at Screening, a personal or family history
of QTc prolongation, congenital long QT syndrome, or subjects who are receiving drugs
that prolong the QTc interval, such as Class Ia or Class III antiarrhythmic agents,
erythromycin, and certain antipsychotics (eg, ziprasidone)

- Hemoglobin < 12 g/dL for males or < 11g/dL for females at Screening

- History of bariatric surgery at any time in the past or any other surgery < 2 months
before Screening; or any planned surgery that in the opinion of the investigator
might have an effect on glucose homeostasis

- Any other hospitalization in the 14 days prior to Screening or planned
hospitalization at any time during the study

- Significant weight change (± 5%) < 2 months prior to Screening

- Undergoing any type of dialysis at Screening or planning to undergo any type of
dialysis during the course of the study

- History of liver cirrhosis

- Treatment with strong or moderate CYP3A inhibitors within 14 days prior to Period 2
Day 1

- Treatment with CYP3A inducers or P-gp inducers within 14 days prior to Period 2 Day 1

- Treatment with CYP3A4 substrates with a narrow therapeutic range (eg, cyclosporine,
tacrolimus, or sirolimus) within 14 days prior to Period 2 Day 1

- Treatment with simvastatin at a dose of > 20 mg daily within 14 days prior to Period
2 Day 1

- Use of OHAs other than SU agents or metformin, including but not limited to
dipeptidyl peptidase-4 inhibitors (eg, saxagliptin and sitagliptin) and glucagon-like
peptide-mimetics (eg, exenatide) < 3 months prior to Screening. Use of
thiazolidinediones (TZDs) (eg, rosiglitazone or pioglitazone) < 6 months prior to
Screening

- Weight loss medication or anti-obesity medication (prescription or non prescription)
< 3 months prior to Screening

- Treatment with niacin > 200 mg daily; if receiving > 200 mg daily, should be on
stable doses for ≥ 3 months prior to Screening

- Expected or current treatment with systemic corticosteroids (oral or injectable) for
> 14 days from Screening through the end of Period 2. Topical or inhaled
corticosteroid formulations are permitted at any time during the study.

- If receiving thyroid replacement therapy, should be on stable doses for at least 6
weeks prior to Period 2 Day 1
We found this trial at
43
sites
Bristol, Tennessee 37620
?
mi
from
Bristol, TN
Click here to add this to my saved trials
5323 Harry Hines Blvd
Dallas, Texas 75235
(214) 648-3111
Univ of Texas, Southwestern Med Ctr of Dallas The story of UT Southwestern Medical Center...
?
mi
from
Dallas, TX
Click here to add this to my saved trials
2010 Wilshire Boulevard
Los Angeles, California 90057
213-413-2500
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
3288 Illinois Avenue
Louisville East, Kentucky 40217
502-214-3990
?
mi
from
Louisville East, KY
Click here to add this to my saved trials
3890 Tampa Rd # 302
Palm Harbor, Florida 34684
?
mi
from
Palm Harbor, FL
Click here to add this to my saved trials
1045 East 3900 South
Salt Lake City, Utah 84124
801-261-2000
?
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
5109 Medical Drive
San Antonio, Texas 78229
210-433-6222
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
Albuquerque, New Mexico
?
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Alpena, Michigan 49707
?
mi
from
Alpena, MI
Click here to add this to my saved trials
Atlanta, Georgia 30127
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
Battle Creek, Michigan 49015
?
mi
from
Battle Creek, MI
Click here to add this to my saved trials
Beavercreek, Ohio 45431
?
mi
from
Beavercreek, OH
Click here to add this to my saved trials
Brandon, Florida 33511
?
mi
from
Brandon, FL
Click here to add this to my saved trials
Charlotte, North Carolina 28209
?
mi
from
Charlotte, NC
Click here to add this to my saved trials
Chicago, Illinois 60607
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Chula Vista, California 91910
?
mi
from
Chula Vista, CA
Click here to add this to my saved trials
Eagle, Idaho 83616
?
mi
from
Eagle, ID
Click here to add this to my saved trials
?
mi
from
Eunice, LA
Click here to add this to my saved trials
Fountain Valley, California 92708
?
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Fresno, California 93720
?
mi
from
Fresno, CA
Click here to add this to my saved trials
Gainesville, Florida 32605
?
mi
from
Gainesville, FL
Click here to add this to my saved trials
Greensboro, North Carolina 27408
?
mi
from
Greensboro, NC
Click here to add this to my saved trials
?
mi
from
Houston, TX
Click here to add this to my saved trials
Houston, Texas 77081
?
mi
from
Houston, TX
Click here to add this to my saved trials
Humble, Texas 77338
?
mi
from
Humble, TX
Click here to add this to my saved trials
Huntington Park, California 90255
?
mi
from
Huntington Park, CA
Click here to add this to my saved trials
Knoxville, Tennessee 37923
?
mi
from
Knoxville, TN
Click here to add this to my saved trials
?
mi
from
Mesa, AZ
Click here to add this to my saved trials
Miami Beach, Florida 33140
?
mi
from
Miami Beach, FL
Click here to add this to my saved trials
?
mi
from
Michigan City, IN
Click here to add this to my saved trials
Moreno Valley, California 92553
?
mi
from
Moreno Valley, CA
Click here to add this to my saved trials
Oklahoma City, Oklahoma 73103
?
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Oxon Hill, Maryland 20745
?
mi
from
Oxon Hill, MD
Click here to add this to my saved trials
Pine Bluff, Arkansas 71603
?
mi
from
Pine Bluff, AR
Click here to add this to my saved trials
?
mi
from
Sacramento, CA
Click here to add this to my saved trials
Salt Lake City, Utah 84124
?
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
South Miami, Florida 33143
?
mi
from
South Miami, FL
Click here to add this to my saved trials
St Petersburg, Florida 33716
?
mi
from
St Petersburg, FL
Click here to add this to my saved trials
Taylors, South Carolina 29687
?
mi
from
Taylors, SC
Click here to add this to my saved trials
Towson, Maryland 21204
?
mi
from
Towson, MD
Click here to add this to my saved trials
Tucson, Arizona 85710
?
mi
from
Tucson, AZ
Click here to add this to my saved trials
West Hills, California 91307
?
mi
from
West Hills, CA
Click here to add this to my saved trials
Winter Haven, Florida 33880
?
mi
from
Winter Haven, FL
Click here to add this to my saved trials